Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 6, 2022
- Accession no.
- 0001209191-22-048781
- Filed
- Sep 6, 2022
- Trade date
- Sep 1, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $19.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Common Stock | SSaleDisposed | −392 | $17.89 | −$7,012.88 | 45,919 | Direct | |
| Sep 1, 2022 | Common Stock | SSaleDisposed | −690 | $17.88 | −$12,337.2 | 45,229 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.